查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1347715

结核病诊断市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

市场概况：

2022年，全球结核病诊断市场规模达到24亿美元。展望未来，IMARC集团预计到2028年市场规模将达到32亿美元，2023-2028年復合年增长率（CAGR）为5.28%。

结核病 (TB) 是一种传染性细菌性疾病，主要影响肺部（肺）以及身体其他部位（肺外）。感染可通过曼图结核菌素皮试 (TST) 或结核血检来诊断。根据受感染的器官，需要进行额外的测试来确认结核病。对于肺结核，需要进行胸部X光检查以检测胸部异常，并对患者的痰液进行抗酸染色和显微镜检查。肺外结核可以通过 CT、MRI 或超声波扫描、内窥镜检查、腹腔镜检查、尿液和血液检查、活检和腰椎穿刺来诊断。

结核病诊断市场趋势：

全球耐多药（MDR）结核病患病率的不断上升是推动市场增长的关键因素之一。耐多药结核病是由对异烟肼和利福平耐药的细菌引起的，异烟肼和利福平被认为是治疗结核病最有效的抗菌药物之一。此外，技术先进的即时护理（POC）诊断方法的出现也推动了市场的增长。与传统使用的技术相比，核酸扩增测试 (NAAT) 和干扰素伽马释放测定 (IGRA) 等先进的诊断方法更加准确、方便，并且可以提供及时的结果。此外，医疗保健基础设施的显着改善，以及大众对各种诊断程序的认识不断增强，是另一个促进增长的因素。其他因素，包括老年人口的增加、医疗保健支出的增加以及政府促进研发 (R&D) 活动的倡议和投资，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球结核病诊断市场表现如何？未来几年将如何表现？
  • 主要区域市场有哪些？
  • COVID-19 对全球结核病诊断市场有何影响？
  • 根据疾病阶段，市场的细分是什么？
  • 根据测试类型，市场的细分是什么？
  • 基于最终用户的市场细分是什么？
  • 行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球结核病诊断市场的结构如何？谁是主要参与者？
  • 行业竞争程度如何？

目录

第一章：前言

第 2 章：范围和方法

  • 研究目的
  • 利益相关者
  • 数据源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球结核病诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按疾病阶段分類的市场细分

  • 潜伏性结核病
    • 市场走向
    • 市场预测
  • 活动性结核病
    • 市场走向
    • 市场预测

第 7 章：按测试类型分類的市场

  • 射线照相测试
    • 市场走向
    • 市场预测
  • 实验室测试
    • 市场走向
    • 主要类型
      • 涂片显微镜
      • 基于文化的测试
    • 市场预测
  • 核酸检测
    • 市场走向
    • 市场预测
  • 细胞因子检测试验
    • 市场走向
    • 市场预测
  • 耐药性测试
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场细分

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 诊断和研究实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场细分

  • 北美
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳大利亚
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉美
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格指标

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Alere Inc.
    • Becton Dickinson and Company
    • BioMerieux
    • Cepheid Inc.
    • Epistem Ltd.
    • Roche Holding AG
    • Hain Lifescience GmbH
    • Hologic Inc.
    • QIAGEN GmbH
    • Siemens
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2047

Market Overview:

The global tuberculosis diagnostics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028.

Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient's sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

Tuberculosis Diagnostics Market Trends:

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease stage, test type, and end-user.

Breakup by Disease Stage:

Latent TB

Active TB

Breakup by Test Type:

Radiographic Test

Laboratory Test

Smear Microscopy

Culture-based Test

Nucleic Acid Testing

Cytokine Detection Test

Drug Resistance Test

Others

Breakup by End-User:

Hospitals and Clinics

Diagnostics and Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMerieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tuberculosis Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Stage

  • 6.1 Latent TB
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Active TB
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Radiographic Test
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Smear Microscopy
      • 7.2.2.2 Culture-based Test
    • 7.2.3 Market Forecast
  • 7.3 Nucleic Acid Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cytokine Detection Test
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Drug Resistance Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Research Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alere Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Epistem Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Roche Holding AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Hain Lifescience GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2022
  • Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2022
  • Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Tuberculosis Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2023-2028
  • Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
  • Table 7: Global: Tuberculosis Diagnostics Market: Key Players